Details
- Close date
- No date set
- Academic background
- Business, Health Sciences, Sciences
- Host campus
- Dunedin
- Qualification
- PhD
- Supervisor
- Dr Ross Wilson, Professor Haxby Abbott
Overview
Randomised controlled trials are the gold standard for evaluating the efficacy and effectiveness of healthcare interventions. Pragmatic randomised trials in particular – in which patients are recruited when seeking medical treatment, the control arm of the trial is usual care, and patient-relevant outcomes are collected over longer-term follow-up – are ideally suited to also answering questions about cost-effectiveness and of the health system and broader economic benefits of healthcare interventions.
Conducting cost-effectiveness analysis and economic evaluation within clinical trials poses several statistical and methodological challenges beyond those involved in the analysis of clinical trial outcomes, however tools and guidance for these analyses remain in their infancy. We have an opportunity for a PhD student to contribute to a project reviewing and developing methodological guidelines for clinical trial-based economic evaluation, developing statistical software tools to support the implementation of identified best practice methods, and applying these tools to existing and ongoing randomised trial data.
The project would suit a student with qualifications in economics, statistics, epidemiology or a related field. Strengths in applied mathematics and coding would be an advantage.
There is no funding currently available for this project, and students would be expected to seek scholarship funding via University of Otago scholarships or other sources to support their study. If you are a straight A student (GPA of 8 – 'A' grade) or higher, who has completed an Honours or Master's degree with an appropriate research component from a New Zealand university then you are likely to be guaranteed a University of Otago Doctoral Scholarship.